These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

770 related items for PubMed ID: 11057120

  • 1. [HMG-CoA reductase inhibitors in prevention of cardiovascular diseases: new mechanisms, aspects and trials].
    Wojakowski W, Gmiński J.
    Przegl Lek; 2000; 57(5):291-5. PubMed ID: 11057120
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR, Noll G, Lüscher TP.
    Schweiz Med Wochenschr; 1997 Apr 12; 127(15):636-49. PubMed ID: 9198890
    [Abstract] [Full Text] [Related]

  • 4. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.
    Ong HT.
    QJM; 2005 Aug 12; 98(8):599-614. PubMed ID: 16006501
    [Abstract] [Full Text] [Related]

  • 5. Protecting the heart: a practical review of the statin studies.
    Ong HT.
    MedGenMed; 2002 Dec 10; 4(4):1. PubMed ID: 12817199
    [Abstract] [Full Text] [Related]

  • 6. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Bocan TM.
    Curr Opin Investig Drugs; 2002 Sep 10; 3(9):1312-7. PubMed ID: 12498006
    [Abstract] [Full Text] [Related]

  • 7. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S, Ridker PM.
    Am J Cardiol; 2006 Jan 16; 97(2A):33A-41A. PubMed ID: 16442935
    [Abstract] [Full Text] [Related]

  • 8. Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease.
    Sadowitz B, Maier KG, Gahtan V.
    Vasc Endovascular Surg; 2010 May 16; 44(4):241-51. PubMed ID: 20403949
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cholesterol 2001. Rationale for lipid-lowering in older patients with or without CAD.
    Aronow WS.
    Geriatrics; 2001 Sep 16; 56(9):22-5, 28-30. PubMed ID: 11582971
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Statins: possibly more than just lowering of the lipid level].
    Visseren FL, Lansberg PJ, Erkelens DW, Kastelein JJ.
    Ned Tijdschr Geneeskd; 2000 Feb 12; 144(7):316-21. PubMed ID: 10707742
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE.
    J Cardiovasc Pharmacol; 2008 Apr 12; 51(4):331-51. PubMed ID: 18427276
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Advances in cholesterol-lowering interventions].
    Ascaso JF.
    Endocrinol Nutr; 2010 May 12; 57(5):210-9. PubMed ID: 20451478
    [Abstract] [Full Text] [Related]

  • 20. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group.
    J Womens Health (Larchmt); 2004 Dec 12; 13(10):1101-7. PubMed ID: 15650343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.